These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 2858583)
1. Effects of H2-receptor antagonists upon physiological acid secretory states in animals. Pendleton RG; Cook PG; Shepherd-Rose A; Mangel AW J Pharmacol Exp Ther; 1985 Apr; 233(1):64-9. PubMed ID: 2858583 [TBL] [Abstract][Full Text] [Related]
2. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine. Cavanagh RL; Usakewicz JJ; Buyniski JP J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316 [TBL] [Abstract][Full Text] [Related]
3. Actions of nizatidine, a selective histamine H2-receptor antagonist, on gastric acid secretion in dogs, rats and frogs. Lin TM; Evans DC; Warrick MW; Pioch RP J Pharmacol Exp Ther; 1986 Nov; 239(2):406-10. PubMed ID: 2877081 [TBL] [Abstract][Full Text] [Related]
4. Effects of ORF 17583, other histamine H2-receptor antagonists and omeprazole on gastric acid secretory states in rats and dogs. Katz LB; Tobia AJ; Shriver DA J Pharmacol Exp Ther; 1987 Aug; 242(2):437-42. PubMed ID: 2886642 [TBL] [Abstract][Full Text] [Related]
5. Control of gastric acid secretion. Histamine H2-receptor antagonists and H+K(+)-ATPase inhibitors. Shamburek RD; Schubert ML Gastroenterol Clin North Am; 1992 Sep; 21(3):527-50. PubMed ID: 1355465 [TBL] [Abstract][Full Text] [Related]
6. The antisecretory profile of action of the H2-receptor antagonists, famotidine, loxtidine, ranitidine and L-643,441 on the rat isolated gastric mucosa. Reeves JJ; Stables R Agents Actions; 1987 Feb; 20(1-2):22-8. PubMed ID: 2883848 [TBL] [Abstract][Full Text] [Related]
7. Gastroprokinetic activity of nizatidine, a new H2-receptor antagonist, and its possible mechanism of action in dogs and rats. Ueki S; Seiki M; Yoneta T; Aita H; Chaki K; Hori Y; Morita H; Tagashira E; Itoh Z J Pharmacol Exp Ther; 1993 Jan; 264(1):152-7. PubMed ID: 8093722 [TBL] [Abstract][Full Text] [Related]
8. Effect of a new potent H2-blocker, 3-]]]2-[(diaminomethylene)amino]-4-thiazolyl]methyl]-thio]-N2-sulfamoylpropionamidine (YM-11170) on gastric secretion induced by histamine and food in conscious dogs. Takagi T; Takeda M; Maeno H Arch Int Pharmacodyn Ther; 1982 Mar; 256(1):49-58. PubMed ID: 6124219 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of gastric acid secretion by omeprazole in the dog and rat. Larsson H; Carlsson E; Junggren U; Olbe L; Sjöstrand SE; Skånberg I; Sundell G Gastroenterology; 1983 Oct; 85(4):900-7. PubMed ID: 6884713 [TBL] [Abstract][Full Text] [Related]
10. The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro. Wallmark B; Lorentzon P; Larsson H Scand J Gastroenterol Suppl; 1985; 108():37-51. PubMed ID: 2988109 [TBL] [Abstract][Full Text] [Related]
11. Effect of nizatidine and cimetidine on betazole-stimulated gastric secretion of normal subjects: comparison of effects on acid, water, and pepsin. Hammond JB; Offen WW Am J Gastroenterol; 1988 Jan; 83(1):32-6. PubMed ID: 2892392 [TBL] [Abstract][Full Text] [Related]
12. Tiotidine, a new long-acting histamine H2-receptor antagonist: comparison with cimetidine. Richardson CT; Feldman M; Brater C; Welborn J Gastroenterology; 1981 Feb; 80(2):301-6. PubMed ID: 6108895 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological regulation of gastric acid secretion in the apical membrane of parietal cells; a new target for antisecretory drugs. Okabe S; Shimosako K; Amagase K J Physiol Pharmacol; 2001 Dec; 52(4 Pt 1):639-56. PubMed ID: 11787764 [TBL] [Abstract][Full Text] [Related]
14. The effect of secretagogue selection on potency determinations for gastric acid antisecretory agents. Palumbo GJ; Nielsen ST Methods Find Exp Clin Pharmacol; 1988 Mar; 10(3):151-5. PubMed ID: 2898575 [TBL] [Abstract][Full Text] [Related]
16. Validation of a conscious rat model for the discovery of novel agents that inhibit gastric acid secretion. Campbell CA; Gaskin PJ; Darton J; Chiu P; Lee K; McLean PG Eur J Pharmacol; 2008 Jul; 589(1-3):260-3. PubMed ID: 18571645 [TBL] [Abstract][Full Text] [Related]
17. Potentiation of the gastric antisecretory activity of histamine H2-receptor antagonists by clebopride. Fernández AG; Massingham R; Roberts DJ Methods Find Exp Clin Pharmacol; 1988 May; 10(5):285-93. PubMed ID: 2899659 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological comparison of ORF 17910, a potent, long-acting histamine H2-receptor antagonist, to cimetidine and ranitidine. Katz LB; Scott CK; Shriver DA J Pharmacol Exp Ther; 1986 Aug; 238(2):587-93. PubMed ID: 2874214 [TBL] [Abstract][Full Text] [Related]
19. Acute effects of ranitidine, famotidine and omeprazole on plasma gastrin in the rat. Decktor DL; Pendleton RG; Kellner AT; Davis MA J Pharmacol Exp Ther; 1989 Apr; 249(1):1-5. PubMed ID: 2565384 [TBL] [Abstract][Full Text] [Related]
20. Antisecretory effects of a novel and long-lasting histamine H2-receptor antagonist, YM-14471, in rats and dogs. Yuki H; Kamato T; Nishida A; Fujihara A; Takeda M; Miyata K Jpn J Pharmacol; 1993 Nov; 63(3):345-51. PubMed ID: 7906319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]